222 related articles for article (PubMed ID: 17433223)
1. [TP53 and RB tumor suppressor pathways collaborate in retinoblastoma genesis].
Ayrault O; Zindy F; Roussel MF
Med Sci (Paris); 2007 Apr; 23(4):356-8. PubMed ID: 17433223
[No Abstract] [Full Text] [Related]
2. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
Morris M; Hepburn P; Wynford-Thomas D
Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
[TBL] [Abstract][Full Text] [Related]
3. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle control and cancer.
Sherr CJ
Harvey Lect; 2000-2001; 96():73-92. PubMed ID: 12200872
[No Abstract] [Full Text] [Related]
5. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
6. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of several tumor suppressor genes in primary retinoblastoma].
Huang Q; Tao Y; Yandell DW
Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785
[TBL] [Abstract][Full Text] [Related]
8. RB regulates the stability and the apoptotic function of p53 via MDM2.
Hsieh JK; Chan FS; O'Connor DJ; Mittnacht S; Zhong S; Lu X
Mol Cell; 1999 Feb; 3(2):181-93. PubMed ID: 10078201
[TBL] [Abstract][Full Text] [Related]
9. Lack of detection of p53 expression in retinoblastoma tumor cells.
Faraldi F; Calzolari A; Alfieri E; Mincione GP; Mincione F
Pathologica; 1994 Aug; 86(4):401-2. PubMed ID: 7708441
[TBL] [Abstract][Full Text] [Related]
10. Targeting the p53 pathway in retinoblastoma with subconjunctival Nutlin-3a.
Brennan RC; Federico S; Bradley C; Zhang J; Flores-Otero J; Wilson M; Stewart C; Zhu F; Guy K; Dyer MA
Cancer Res; 2011 Jun; 71(12):4205-13. PubMed ID: 21515735
[TBL] [Abstract][Full Text] [Related]
11. Primary and secondary glioblastomas: from concept to clinical diagnosis.
Kleihues P; Ohgaki H
Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
13. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
Skomedal H; Kristensen GB; Nesland JM; Børresen-Dale AL; Tropé C; Holm R
J Pathol; 1999 Apr; 187(5):556-62. PubMed ID: 10398121
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and tumor-suppressor genes.
Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
[TBL] [Abstract][Full Text] [Related]
15. Contributions of differential p53 expression in the spontaneous immortalization of a chicken embryo fibroblast cell line.
Christman SA; Kong BW; Landry MM; Kim H; Foster DN
BMC Cell Biol; 2006 Jun; 7():27. PubMed ID: 16813656
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of p53 and RB pathways in epithelial ovarian cancer.
Hashiguchi Y; Tsuda H; Yamamoto K; Inoue T; Ishiko O; Ogita S
Hum Pathol; 2001 Sep; 32(9):988-96. PubMed ID: 11567230
[TBL] [Abstract][Full Text] [Related]
18. [pRB, p53, p16INK4a, senescence and malignant transformation].
Larsen CJ
Bull Cancer; 2004 May; 91(5):399-402. PubMed ID: 15281278
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the p53 pathway in retinoblastoma.
Laurie NA; Donovan SL; Shih CS; Zhang J; Mills N; Fuller C; Teunisse A; Lam S; Ramos Y; Mohan A; Johnson D; Wilson M; Rodriguez-Galindo C; Quarto M; Francoz S; Mendrysa SM; Guy RK; Marine JC; Jochemsen AG; Dyer MA
Nature; 2006 Nov; 444(7115):61-6. PubMed ID: 17080083
[TBL] [Abstract][Full Text] [Related]
20. Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression.
Wang J; Ding S; Duan Z; Xie Q; Zhang T; Zhang X; Wang Y; Chen X; Zhuang H; Lu F
Oncogene; 2016 Mar; 35(13):1692-702. PubMed ID: 26119940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]